The systemic inflammatory response and clinicopathological characteristics in patients admitted to hospital with COVID-19 infection: Comparison of 2 consecutive cohorts

Donogh Maguire; Conor Richards; Marylynne Woods; Ross Dolan; Jesse Wilson Veitch; Wei MJ Sim; Olivia EH Kemmett; David C Milton; Sophie LW Randall; Ly D Bui; Nicola Goldmann; Amy Brown; Eilidh Gillen; Allan Cameron; Barry Laird; Dinesh Talwar; Ian M Godber; John Wadsworth; Anthony Catchpole; Alan Davidson; Donald C McMillan

doi:10.1101/2021.02.04.21250932

Abstract

Background In order to manage the COVID-19 systemic inflammatory response, it is important to identify clinicopathological characteristics across multiple cohorts.

Methods Electronic patient records for 2 consecutive cohorts of patients admitted to two urban teaching hospitals with COVID-19 during two 7-week periods of the COVID-19 pandemic in Glasgow, U.K. (cohort 1: 17^th March 2020 – 1^st May 2020) and (cohort 2: 18^th May 2020 – 6^th July 2020) were examined for routine clinical, laboratory and clinical outcome data.

Results Compared with cohort 1, cohort 2 were older (p<0.001), more likely to be female (p<0.05) and have less independent living circumstances (p<0.001). More patients in cohort 2 were PCR positive, CXR negative (both p<0.001) and had low serum albumin concentrations (p<0.001). 30-day mortality was similar between both cohorts (23% and 22%). Over the 2 cohorts, age ≥70 (p<0.001), male gender (p<0.05), hypertension (p<0.01), heart failure (p<0.05), cognitive impairment (p<0.001), frailty (p<0.001), COPD (p<0.05), delirium (p<0.001), elevated perioperative Glasgow Prognostic Score (p≤0.001), elevated neutrophil-lymphocyte ratio (p<0.001), low haematocrit (p<0.01), elevated urea (p<0.001), creatinine (p<0.001), glucose (p<0.05) and lactate (p<0.01); and the 4C score were associated with 30-day mortality. When compared with the 4C score, greater frailty (OR 10.2, 95% C.I. 3.4 – 30.6, p<0.01) and low albumin (OR 5.6, 95% C.I. 2.0 – 15.6, p<0.01) were strongly independently associated with 30-day mortality.

Conclusion In addition to the 4C mortality score, frailty score and a low albumin were strongly independently associated with 30-day mortality in two consecutive cohorts of patients admitted to hospital with COVID-19.

Article summary

In two consecutive cohorts of patients with COVID-19 infection admitted to two urban teaching hospitals in Glasgow, UK, there were variations in a number of clinicopathological characteristics despite similar mortality (23 and 22%).
In these two cohorts, in a multivariate analysis that included the 4C mortality score, clinical frailty score >3, low serum albumin concentration (<35 g/L), high neutrophil-lymphocyte ratio (≥5), and abnormal serum sodium concentration (<133/>145 mmol/L) remained independently associated with 30-day mortality.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

clinicaltrials.gov: NCT04484545

Clinical Protocols

https://clinicaltrials.gov/ct2/show/NCT04484545

Funding Statement

No funding received

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

In line with NHS policy, the NHS Greater Glasgow and Clyde Caldicott guardian approved this study. The study protocol (GN20AE307) was approved by the North West England-Preston research ethics committee (20/NW/0336) and registered with clinicaltrials.gov (NCT04484545).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data will be available via clinical trials. com. Authors must be cited.

https://clinicaltrials.gov/ct2/show/NCT04484545

Abbreviations

(SARS-CoV-2 infection): COVID-19
(SIRS): systemic inflammatory response syndrome
(ISARIC): International Severe Acute Respiratory and emerging Infections Consortium
(WHO): World Health Organization
(CCP-UK): Clinical Characterisation Protocol UK
(4C mortality score): study (performed by the ISARIC Coronavirus Clinical Characterisation Consortium—ISARIC-4C)
(NEWS): national early warning score
(PCR): Polymerase chain reaction
(poGPS): peri-operative Glasgow Prognostic Score
(NLR): neutrophil lymphocyte ratio
(CRP): serum C-reactive protein
(GRI): Glasgow Royal Infirmary
(QEUH): Queen Elizabeth University Hospital
(ED): Emergency Department
(AAU): Acute Assessment Unit
(CXR): chest X-ray
(BMI): Body mass index
(CFS): Clinical Frailty Scale
(AVPU scale): Alert (A), responding to verbal (V), painful (P) stimuli and unresponsive (U)
(SIMD): Scottish Indices of Multiple Deprivation
(χ² test): Chi-squared test

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.